Lymphatic vessels are present in phosphaturic mesenchymal tumours

Virchows Archiv

Volumn 451, Issue 5, 2007, Pages 871-875

  Williams, K ^a   Flanagan, A ^b   Folpe, A ^c   Thakker, R ^d   Athanasou, N A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c EMORY UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Lymphatics; Osteomalacia; Phosphaturic mesenchymal tumour; Vascular tumour

Indexed keywords

CELL ANTIGEN; FIBROBLAST GROWTH FACTOR 23; LYVE 1 ANTIGEN; MONOCLONAL ANTIBODY; PODOPLANIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; CLINICAL ARTICLE; CONNECTIVE TISSUE TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMANGIOMA; HEMANGIOPERICYTOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOMA; MALE; OSTEOMALACIA; PHOSPHATURIC MESENCHYMAL TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION;

BONE NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; LYMPHATIC VESSELS; MALE; MEMBRANE GLYCOPROTEINS; MESENCHYMOMA; MIDDLE AGED; OSTEOMALACIA; PHOSPHATES;

EID: 35848945915     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0471-y     Document Type: Review

References (23)

1. Aschinberg LC, Solomon LM, Zeis PM, Justice P, Rosenthal IM (1977) Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J Pediatr 91:56-60
2. Auguste P, Javerzat S, Bikfalvi A (2003) Regulation of vascular development by fibroblast growth factors. Cell Tissue Res 314:157-166
3. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801
4. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D (1999) Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394
5. Cotton GE (1994) Oncogenic osteomalacia. N Engl J Med 331:1023
6. De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC (2002) Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 17:1102-1110
7. Drezner MK (1999) Tumour-induced osteomalacia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams and Wilkins, Washington, pp 331-337
8. Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1-30
9. Fukumoto S, Yamashita T (2002) Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Curr Opin Nephrol Hypertens 11:385-389
10. Haviv YS, Silver J (2000) Late onset oncogenic osteomalacia-associated with neurofibromatosis type II. Clin Nephrol 54:429-430
11. Hultberg BM, Svanholm H (1989) Immunohistochemical differentiation between lymphangiographically verified lymphatic vessels and blood vessels. Virchows Arch A Pathol Anat Histopathol 414:209-215
12. Kubo H, Cao R, Brakenhielm E, Makinen T, Cao Y, Alitalo K (2002) Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A 99:8868-8873
13. Lever EG, Pettingale KW (1983) Albright's syndrome associated with a soft-tissue myxoma and hypophosphataemic osteomalacia. Report of a case and review of the literature. J Bone Joint Surg Br 65:621-626
14. McMurtry CT, Godschalk M, Malluche HH, Geng Z, Adler RA (1993) Oncogenic osteomalacia associated with metastatic prostate carcinoma: case report and review of the literature. J Am Geriatr Soc 41:983-985
15. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683-692
16. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K (1998) Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 46:165-176
17. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500-6505
18. Shin JW, Min M, Larrieu-Lahargue F, Canron X, Kunstfeld R, Nguyen L, Henderson JE, Bikfalvi A, Detmar M, Hong YK (2006) Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17:576-584
19. Takeuchi Y, Suzuki H, Ogura S, Imai R, Yamazaki Y, Yamashita T, Miyamoto Y, Okazaki H, Nakamura K, Nakahara K, Fukumoto S, Fujita T (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89:3979-3982
20. Turner RR, Beckstead JH, Warnke RA, Wood GS (1987) Endothelial cell phenotypic diversity. In situ demonstration of immunologic and enzymatic heterogeneity that correlates with specific morphologic subtypes. Am J Clin Pathol 87:569-575
21. Weidner N, Bar RS, Weiss D, Strottmann MP (1985) Neoplastic pathology of oncogenic osteomalacia/rickets. Cancer 55:1691-1705
22. Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59:1442-1454
23. Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA (2004) Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum Pathol 35:857-861